June 2018
A multicenter observational study in Japan published in the Frontiers in Clinical Diabetes and Healthcare found that individuals with type 2 diabetes taking glucagon-like peptide-1 receptor agonists (GLP-1RAs) showed reduced external eating scores after 12 months of therapy Their blood sugar levels, body weight, and body fat percentage also decreased significantly Emotional and restrained eating showed only transient changes
Genome-wide association studies suggest that glutamatergic neurotransmission and NMDA receptor-mediated synaptic plasticity are important for body weight homeostasis 1
Two regions are defined in the arena: the center, which accounts for 25% of the total area, and the periphery, which accounts for the remaining 75%
3017 Predictors in infancy of disease-specific quality of life in adolescents born with esophageal atresia - a nationwide prospective observational study in Sweden Michaela Dellenmark-Blom 1,2 , Sara Persson 1,2 , Elisabet Gustafsson 3,4 , Erik Omling 5 , Colin Reilly 2 , Helene Engstrand Lilja 6 , Jan F
Even insured patients may end up paying out of pocket for semaglutide
